Insider Stock Trading History of Grange David L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Grange David L since year 2005. The trader's CIK number is 1264908. At the time of this reporting, Grange David L is the Director of Pharmaceutical Product Development Inc . (stock ticker symbol PPDI). See this page for all insider trading activities at Pharmaceutical Product Development Inc .


Stock purchases, sales, and option exercises reported by insider Grange David L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2011-02-28 PPDI Pharmaceutical Product Development Inc Sale 34,501 26.00 897,026
2011-02-28 PPDI Pharmaceutical Product Development Inc Option Ex 34,501 20.45 705,545
2010-11-02 PPDI Pharmaceutical Product Development Inc Option Ex 373 21.98 8,198
2010-11-03 PPDI Pharmaceutical Product Development Inc Option Ex 51,380 21.98 1,129,332
2010-11-02 PPDI Pharmaceutical Product Development Inc Sale 373 26.00 9,698
2010-11-03 PPDI Pharmaceutical Product Development Inc Sale 51,380 25.71 1,320,979
2008-08-07 PPDI Pharmaceutical Product Development Inc Option Ex 10,099 34.60 349,425
2008-08-07 PPDI Pharmaceutical Product Development Inc Sale 10,099 41.35 417,593
2008-08-07 PPDI Pharmaceutical Product Development Inc Option Ex 10,099 34.60 349,425
2008-08-07 PPDI Pharmaceutical Product Development Inc Sale 10,099 41.35 417,593
2007-07-26 PPDI Pharmaceutical Product Development Inc Option Ex 5,458 23.79 129,845
2007-07-26 PPDI Pharmaceutical Product Development Inc Sale 5,458 33.76 184,262
2007-02-09 PPDI Pharmaceutical Product Development Inc Sale 6,000 34.14 204,870
2007-02-09 PPDI Pharmaceutical Product Development Inc Option Ex 6,000 15.06 90,360
2006-05-24 PPDI Pharmaceutical Product Development Inc Option Ex 10,000 15.06 150,600
2006-05-24 PPDI Pharmaceutical Product Development Inc Sale 10,000 36.24 362,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grange David L (Director of Pharmaceutical Product Development Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.